CD44 and breast cancer: To evaluate the killing effect of conditional replication Ad (CRAd) on breast cancer, CD44+CD24− CSCs extracted from the pleural effusion of patients with metastatic breast cancer and injected into the fat pad of SCID mice decreased after tumor formation, which may contribute to the differentiation and proliferation of CSCs to form solid tumors.